IAA
AMGN icon

Ironsides Asset Advisors’s Amgen AMGN Stock Holding History

Ironsides Asset Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,269
Closed -$212K – 147
2016
Q3 		$212K Buy
+1,269
New +$215K 0.06% 151
2016
Q2 		– Sell
-1,770
Closed -$265K – 147
2016
Q1 		$265K Buy
+1,770
New +$263K 0.07% 157

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ironsides Asset Advisors's AMGN Position: Q4 2016 in Review

Ironsides Asset Advisors sold out of Amgen (AMGN) in Q4 2016, closing a stake of 1,269 shares — an estimated $212K sold.

Ironsides Asset Advisors first reported a position in AMGN in Q1 2016 and held it in 2 quarters. The position peaked at $265K in Q1 2016. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

  • Ironsides Asset Advisors reported no remaining Amgen position as of Q4 2016 after selling out during the quarter.
  • Ironsides Asset Advisors sold 1,269 Amgen shares in Q4 2016, an estimated $212K.
  • Ironsides Asset Advisors first reported a position in Amgen in Q1 2016 and held it in 2 quarters.
  • Ironsides Asset Advisors's Amgen position peaked at $265K in Q1 2016.
  • 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on Ironsides Asset Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.